D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 9.92% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Starwood Property Trust
STWD
$6.12B
| $215K | ﹤0.01% |
8,665
-1,682
| -16% | -$41.2K |
|
3727
Future Fuel
FF
$204M
| $214K | ﹤0.01% |
17,235
| – | – |
|
3728
Ichor Holdings
ICHR
$3.02B
| $213K | ﹤0.01% |
+6,400
| New | +$191K |
|
3729
Abbott
ABT
$180B
| $212K | ﹤0.01% |
2,438
-6,353
| -72% | -$532K |
|
|
CUK
3730
DELISTED
Carnival PLC
CUK
| $212K | ﹤0.01% |
4,402
-28,221
| -87% | -$1.19M |
|
3731
Nokia
NOK
$50.8B
| $212K | ﹤0.01% |
57,256
-2,102,573
| -97% | -$8.27M |
|
|
MTSC
3732
DELISTED
MTS Systems Corp
MTSC
| $210K | ﹤0.01% |
4,375
-57,896
| -93% | -$3.08M |
|
3733
Lindblad Expeditions
LIND
$1.76B
| $209K | ﹤0.01% |
+12,813
| New | +$205K |
|
3734
Penske Automotive Group
PAG
$14.3B
| $209K | ﹤0.01% |
4,162
-10,729
| -72% | -$530K |
|
|
DCPH
3735
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $209K | ﹤0.01% |
3,351
-34,338
| -91% | -$1.63M |
|
|
TWO
3736
Two Harbors Investment
TWO
$1.27B
| $208K | ﹤0.01% |
+3,555
| New | +$201K |
|
3737
CALL
Invesco
IVZ
$13.3B
| $207K | ﹤0.01% |
11,500
-2,700
| -19% | -$46.1K |
|
3738
Revolve Group
RVLV
$1.79B
| $206K | ﹤0.01% |
+11,225
| New | +$213K |
|
3739
Cue Biopharma
CUE
$135M
| $205K | ﹤0.01% |
+430
| New | +$135K |
|
3740
Ring Energy
REI
$322M
| $205K | ﹤0.01% |
+77,572
| New | +$152K |
|
|
APRN
3741
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
| $205K | ﹤0.01% |
+2,591
| New | +$235K |
|
3742
Civista Bancshares
CIVB
$594M
| $204K | ﹤0.01% |
+8,503
| New | +$189K |
|
|
GOOS
3743
Canada Goose Holdings
GOOS
$868M
| $204K | ﹤0.01% |
5,627
-1,906
| -25% | -$73.6K |
|
3744
Pioneer Bancorp
PBFS
$445M
| $204K | ﹤0.01% |
13,295
+1,170
| +10% | +$15.8K |
|
|
SPWR
3745
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
| $204K | ﹤0.01% |
+40,007
| New | +$222K |
|
|
CCRN
3746
DELISTED
Cross Country Healthcare
CCRN
| $203K | ﹤0.01% |
17,500
-10,785
| -38% | -$122K |
|
3747
CALL
Scansource
SCSC
$1.12B
| $203K | ﹤0.01% |
+5,500
| New | +$187K |
|
|
NLSN
3748
PUT
DELISTED
Nielsen Holdings plc
NLSN
| $203K | ﹤0.01% |
10,000
| – | – |
|
|
CTRA
3749
CALL
DELISTED
Coterra Energy
CTRA
| $202K | ﹤0.01% |
+11,600
| New | +$202K |
|
3750
Sterling Infrastructure
STRL
$20.3B
| $201K | ﹤0.01% |
14,269
-9,385
| -40% | -$141K |
|
Similar funds
D.E. Shaw & Co's Q4 2019 Portfolio in Review
As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.